Growth Metrics

Boston Scientific (BSX) Current Assets (2016 - 2026)

Boston Scientific's Current Assets history spans 18 years, with the latest figure at $8.7 billion for Q1 2026.

  • On a quarterly basis, Current Assets rose 18.39% to $8.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.7 billion, a 18.39% increase, with the full-year FY2025 number at $8.8 billion, up 27.08% from a year prior.
  • Current Assets hit $8.7 billion in Q1 2026 for Boston Scientific, down from $8.8 billion in the prior quarter.
  • Over the last five years, Current Assets for BSX hit a ceiling of $9.0 billion in Q2 2024 and a floor of $5.1 billion in Q1 2022.
  • Historically, Current Assets has averaged $7.0 billion across 5 years, with a median of $6.9 billion in 2024.
  • Biggest five-year swings in Current Assets: dropped 24.79% in 2022 and later soared 52.75% in 2024.
  • Tracing BSX's Current Assets over 5 years: stood at $5.8 billion in 2022, then rose by 13.09% to $6.5 billion in 2023, then grew by 6.23% to $6.9 billion in 2024, then grew by 27.08% to $8.8 billion in 2025, then decreased by 1.25% to $8.7 billion in 2026.
  • Business Quant data shows Current Assets for BSX at $8.7 billion in Q1 2026, $8.8 billion in Q4 2025, and $8.0 billion in Q3 2025.